NSE: SUDEEPPHRM | BSE: 544619

Expensive Performer

Download real time

862.75 -20.60 (-2.33%)

160.7K NSE+BSE Volume

NSE 17 Jul, 2026 3:31 PM (IST)

9,744.6

Market Cap

Above industry Median

Dividend

Sudeep Pharma has an upcoming dividend of ₹1.500 per share due on 23 Jul 2026 See details

Sudeep Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SUDEEPPHRM, BSE:544619 Sudeep Pharma Ltd.

Search Inside the pdf :

Sudeep Pharma Ltd.

21 Nov 2025

862.75

-2.33%

SUDEEP PHARMA LIMITED

IPO Subscribe: Sudeep Pharma Ltd.

Hem Securities

Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem. Company leverage its inhouse developed technologies for processes such as encapsulation, spray drying, granulation, trituration, liposomal preparations and blending in an effort to drive innovation in its operations. Company have established a presence in both, domestic and international...

Sudeep Pharma has gained 45.49% in the last 1 Year

Sudeep Pharma Ltd.

20 Nov 2025

862.75

-2.33%

SUDEEP PHARMA: IPO Note

IPO Note: Sudeep Pharma Ltd.

IDBI Capital

Sudeep Pharma is a technology driven manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries, supported by in-house capabilities in encapsulation, spray drying, granulation and liposomal preparations. The company is one of the largest producers of food grade iron phosphate and a leading exporter of mineral based ingredients from India, supplying to more than 100 countries. Its regulatory credentials are a key strength, reflected in approvals such as USFDA, WHO-GMP, EXCiPACT and a rare CEP certification for calcium carbonate in the European Union. The company's...

Sudeep Pharma has gained 47.11% in the last 6 Months

Sudeep Pharma Ltd.

20 Nov 2025

862.75

-2.33%